RxDoctor Payments Data

Anthony Yuen, DO

Family Medicine · Summerville, SCNPI 1033476155

Payments from drug & device makers

$541in general payments, 2019–2025

Across 27 payments — averaging $20.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$120
  • AstraZeneca$83
  • Pfizer$58
  • Novartis$57
  • Lilly USA, LLC$53
  • Amgen$39
  • plus $132 from 7 others

What the payments were for

  • Food & beverage$541100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$541 in reported general payments places this provider in the 50th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$148,185
Medicare patients
312
Services billed
3,095

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide48$62,829
OzempicSemaglutide57$58,497
JanuviaSitagliptin Phosphate27$40,298
JardianceEmpagliflozin25$38,530
EliquisApixaban23$28,854
MounjaroTirzepatide20$23,390
XareltoRivaroxaban15$20,835
LinzessLinaclotide12$14,393
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$13,895
Repatha SureclickEvolocumab11$13,475
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,828
SymbicortBudesonide/Formoterol Fumarate15$6,248
Spiriva RespimatTiotropium Bromide11$5,653
Atorvastatin Calcium385$3,661
Rosuvastatin Calcium244$2,725

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$53$86,21968 claims
Novo NordiskOzempic$25$58,49757 claims
Boehringer IngelheimJardiance, Spiriva Respimat$19$44,18336 claims
PfizerEliquis$58$28,85423 claims
AstraZenecaBreztri Aerosphere, Symbicort$83$15,07629 claims
GSKTrelegy Ellipta$120$13,89516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Summerville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →